Takara Bio Inc. (4974.T)
JPY 1002.0
(-0.2%)
JPY 1002.0
(-0.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.02 Billion JPY | -68.46% |
| 2022 | 25.27 Billion JPY | -22.03% |
| 2021 | 33.05 Billion JPY | 81.6% |
| 2020 | 17.73 Billion JPY | 81.88% |
| 2019 | 9.8 Billion JPY | 2.02% |
| 2018 | 8.84 Billion JPY | 36.42% |
| 2017 | 6.77 Billion JPY | 26.1% |
| 2016 | 5.25 Billion JPY | 4.84% |
| 2015 | 4.73 Billion JPY | 20.52% |
| 2014 | 4.16 Billion JPY | 19.95% |
| 2013 | 3.65 Billion JPY | 6.66% |
| 2012 | 3.78 Billion JPY | -47.26% |
| 2011 | 3.21 Billion JPY | 9.49% |
| 2010 | 2.65 Billion JPY | 1.65% |
| 2009 | 2.55 Billion JPY | 2.88% |
| 2008 | 1.6 Billion JPY | -5.72% |
| 2007 | 2.83 Billion JPY | 6.38% |
| 2006 | 1.98 Billion JPY | 33.7% |
| 2005 | 816 Million JPY | 50.98% |
| 2004 | 911 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -508 Million JPY | -113.09% |
| 2023 Q4 | 3.88 Billion JPY | 1164.17% |
| 2023 Q3 | 307 Million JPY | -87.01% |
| 2023 Q2 | 2.36 Billion JPY | 36.04% |
| 2023 Q1 | 1.73 Billion JPY | -29.65% |
| 2023 FY | - JPY | -68.46% |
| 2022 Q3 | 9.72 Billion JPY | 29.41% |
| 2022 FY | - JPY | -22.03% |
| 2022 Q1 | 5.72 Billion JPY | -39.15% |
| 2022 Q2 | 7.51 Billion JPY | 31.26% |
| 2022 Q4 | 2.46 Billion JPY | -74.62% |
| 2021 Q2 | 6.67 Billion JPY | -29.96% |
| 2021 Q3 | 7 Billion JPY | 4.9% |
| 2021 FY | - JPY | 81.6% |
| 2021 Q4 | 9.41 Billion JPY | 34.35% |
| 2021 Q1 | 9.53 Billion JPY | 54.21% |
| 2020 Q4 | 6.18 Billion JPY | 2.44% |
| 2020 Q2 | 4.04 Billion JPY | 136.4% |
| 2020 FY | - JPY | 81.88% |
| 2020 Q1 | 1.7 Billion JPY | -50.06% |
| 2020 Q3 | 6.03 Billion JPY | 49.41% |
| 2019 FY | - JPY | 2.02% |
| 2019 Q2 | 1.62 Billion JPY | -47.14% |
| 2019 Q1 | 3.08 Billion JPY | 6.39% |
| 2019 Q3 | 1.74 Billion JPY | 7.18% |
| 2019 Q4 | 3.42 Billion JPY | 95.99% |
| 2018 Q2 | 2.12 Billion JPY | -11.35% |
| 2018 Q4 | 2.89 Billion JPY | 27.96% |
| 2018 Q3 | 2.26 Billion JPY | 6.54% |
| 2018 Q1 | 2.39 Billion JPY | -18.8% |
| 2018 FY | - JPY | 36.42% |
| 2017 Q3 | 1.82 Billion JPY | 38.8% |
| 2017 Q2 | 1.31 Billion JPY | 29.52% |
| 2017 Q1 | 1.01 Billion JPY | -18.24% |
| 2017 Q4 | 2.95 Billion JPY | 62.11% |
| 2017 FY | - JPY | 26.1% |
| 2016 Q2 | 1.29 Billion JPY | 10.67% |
| 2016 Q3 | 1.92 Billion JPY | 48.38% |
| 2016 FY | - JPY | 4.84% |
| 2016 Q4 | 1.23 Billion JPY | -35.57% |
| 2016 Q1 | 1.17 Billion JPY | -45.28% |
| 2015 Q2 | 1.15 Billion JPY | 63.64% |
| 2015 FY | - JPY | 20.52% |
| 2015 Q4 | 2.14 Billion JPY | 55.86% |
| 2015 Q3 | 1.37 Billion JPY | 19.18% |
| 2015 Q1 | 704 Million JPY | -62.55% |
| 2014 Q3 | 1.13 Billion JPY | 13.09% |
| 2014 Q4 | 1.88 Billion JPY | 66.08% |
| 2014 FY | - JPY | 19.95% |
| 2014 Q1 | 442 Million JPY | -72.92% |
| 2014 Q2 | 1 Billion JPY | 126.47% |
| 2013 Q3 | 874 Million JPY | -24.07% |
| 2013 Q4 | 1.63 Billion JPY | 86.73% |
| 2013 FY | - JPY | 6.66% |
| 2013 Q1 | 57 Million JPY | -96.28% |
| 2013 Q2 | 1.15 Billion JPY | 1919.3% |
| 2012 Q2 | 1.72 Billion JPY | 1.11% |
| 2012 Q4 | 1.53 Billion JPY | 203.17% |
| 2012 Q1 | 1.7 Billion JPY | 23.86% |
| 2012 FY | - JPY | -47.26% |
| 2012 Q3 | -1.48 Billion JPY | -185.93% |
| 2011 Q3 | 1.89 Billion JPY | -0.21% |
| 2011 Q1 | 1.42 Billion JPY | 18.72% |
| 2011 Q4 | 1.37 Billion JPY | -27.27% |
| 2011 FY | - JPY | 9.49% |
| 2011 Q2 | 1.9 Billion JPY | 33.15% |
| 2010 Q2 | 1.6 Billion JPY | 12.45% |
| 2010 FY | - JPY | 1.65% |
| 2010 Q4 | 1.2 Billion JPY | -32.59% |
| 2010 Q3 | 1.78 Billion JPY | 10.88% |
| 2010 Q1 | 1.43 Billion JPY | 41.3% |
| 2009 Q2 | 1.75 Billion JPY | 29.19% |
| 2009 Q4 | 1.01 Billion JPY | -43.46% |
| 2009 Q3 | 1.79 Billion JPY | 1.88% |
| 2009 FY | - JPY | 2.88% |
| 2009 Q1 | 1.36 Billion JPY | 62.68% |
| 2008 Q3 | 1.72 Billion JPY | 53.01% |
| 2008 Q2 | 1.13 Billion JPY | 0.0% |
| 2008 FY | - JPY | -5.72% |
| 2008 Q4 | 836 Million JPY | -51.65% |
| 2007 FY | - JPY | 6.38% |
| 2006 FY | - JPY | 33.7% |
| 2005 FY | - JPY | 50.98% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | -737.489% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | 1743.818% |
| GNI Group Ltd. | 14.48 Billion JPY | 44.619% |
| Linical Co., Ltd. | 1.24 Billion JPY | -543.344% |
| Trans Genic Inc. | 240.95 Million JPY | -3230.124% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 691.803% |
| Soiken Holdings Inc. | -583.2 Million JPY | 1475.843% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 1430.479% |
| AnGes, Inc. | -8.86 Billion JPY | 190.564% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 724.196% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 208.447% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | -6163.514% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 1029.78% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 834.945% |
| CanBas Co., Ltd. | 53.65 Million JPY | -14855.919% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 1134.566% |
| RaQualia Pharma Inc. | -111.8 Million JPY | 7277.038% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 762.19% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 681.104% |
| PeptiDream Inc. | 7.37 Billion JPY | -8.784% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 515.818% |
| Ribomic Inc. | -1.01 Billion JPY | 892.473% |
| SanBio Company Limited | -4.52 Billion JPY | 277.326% |
| Healios K.K. | -3 Billion JPY | 366.844% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 788.291% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 675.995% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 672.325% |
| StemRIM | -2.03 Billion JPY | 494.882% |
| CellSource Co., Ltd. | 1.3 Billion JPY | -514.188% |
| FunPep Company Limited | -952 Million JPY | 942.857% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 1002.829% |
| Stella Pharma Corporation | -723.85 Million JPY | 1208.511% |
| TMS Co., Ltd. | -937 Million JPY | 956.35% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 1134.833% |
| Cuorips Inc. | -518 Million JPY | 1649.035% |
| K Pharma,Inc. | 366.05 Million JPY | -2092.002% |
| ReproCELL Incorporated | 8.24 Million JPY | -97219.588% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | -9024.611% |
| StemCell Institute Inc. | 534.35 Million JPY | -1401.626% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | -3177.59% |
| CellSeed Inc. | -836.51 Million JPY | 1059.217% |